These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15510838)

  • 21. Thalidomide-induced reversible interstitial pneumonitis in a patient with recurrent ovarian cancer.
    Buttin BM; Moore MJ
    Gynecol Oncol; 2008 Dec; 111(3):546-8. PubMed ID: 18191185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pomalidomide-Induced Pulmonary Toxicity in Multiple Myeloma.
    Modi D; Mamdani H; Vettese T
    Am J Med Sci; 2015 Sep; 350(3):241-2. PubMed ID: 26200951
    [No Abstract]   [Full Text] [Related]  

  • 23. Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial.
    Pönisch W; Rozanski M; Goldschmidt H; Hoffmann FA; Boldt T; Schwarzer A; Ritter U; Rohrberg R; Schwalbe E; Uhlig J; Zehrfeld T; Schirmer V; Haas A; Kreibich U; Niederwieser D;
    Br J Haematol; 2008 Oct; 143(2):191-200. PubMed ID: 18752593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Case of polymer fume fever with interstitial pneumonia caused by inhalation of polytetrafluoroethylene (Teflon)].
    Son M; Maruyama E; Shindo Y; Suganuma N; Sato S; Ogawa M
    Chudoku Kenkyu; 2006 Jul; 19(3):279-82. PubMed ID: 16922460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of isoniazid sodium methanesulfonate induced interstitial pneumonia].
    Matsushima H; Sugita Y; Yanagisawa T; Ubukata M; Kurosawa T; Yoshida F; Kanazawa M
    Kekkaku; 2003 May; 78(5):401-6. PubMed ID: 12806983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Low-dose thalidomide in refractory and relapsing multiple myeloma].
    Radocha J; Maisnar V
    Vnitr Lek; 2007 Feb; 53(2):129-34. PubMed ID: 17419173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thalidomide may induce interstitial pneumonia preferentially in Japanese patients.
    Sasaki M; Isobe Y; Tsukune Y; Kawahara S; Hamano Y; Ando J; Tomomatsu J; Tsutsui M; Sugimoto K
    Eur J Haematol; 2009 Jan; 82(1):73-4. PubMed ID: 18754854
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients.
    Badros AZ; Goloubeva O; Rapoport AP; Ratterree B; Gahres N; Meisenberg B; Takebe N; Heyman M; Zwiebel J; Streicher H; Gocke CD; Tomic D; Flaws JA; Zhang B; Fenton RG
    J Clin Oncol; 2005 Jun; 23(18):4089-99. PubMed ID: 15867202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thalidomide induced impotence in male hematology patients: a common but ignored complication?
    Murphy PT; O'Donnell JR
    Haematologica; 2007 Oct; 92(10):1440. PubMed ID: 18024384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Left atrial thrombus in multiple myeloma treated with thalidomide].
    Jégo C; Barbou F; Laurent P; Gisserot O; Cellarier G; Bonal J; Bouchiat C; Landais C; de Jaureguiberry JP; Dussarat GV
    Arch Mal Coeur Vaiss; 2003 Oct; 96(10):1006-10. PubMed ID: 14653064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial.
    Dingli D; Rajkumar SV; Nowakowski GS; Gertz MA; Dispenzieri A; Lacy MQ; Hayman S; Fonseca R; Lust JA; Kyle RA; Greipp PR; Witzig TE
    Haematologica; 2005 Dec; 90(12):1650-4. PubMed ID: 16330438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Deep vein thrombosis and pulmonary embolism in a patient with multiple myeloma treated with thalidomide and dexamethasone].
    Miyazawa Y; Irisawa H; Uchiumi H; Saitoh T; Handa H; Matsushima T; Tsukamoto N; Karasawa M; Murakami H; Nojima Y
    Rinsho Ketsueki; 2006 Jul; 47(7):656-60. PubMed ID: 16910577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thalidomide in combination with vincristine, epirubicin and dexamethasone (VED) for previously untreated patients with multiple myeloma.
    Schütt P; Ebeling P; Buttkereit U; Brandhorst D; Opalka B; Hoiczyk M; Flasshove M; Hense J; Bojko P; Metz K; Moritz T; Seeber S; Nowrousian MR
    Eur J Haematol; 2005 Jan; 74(1):40-6. PubMed ID: 15613105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thalidomide-dexamethasone plus pegylated liposomal doxorubicin vs. thalidomide-dexamethasone: a case-matched study in advanced multiple myeloma.
    Offidani M; Bringhen S; Corvatta L; Falco P; Marconi M; Avonto I; Piersantelli MN; Polloni C; Boccadoro M; Leoni P; Palumbo A
    Eur J Haematol; 2007 Apr; 78(4):297-302. PubMed ID: 17286608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous melphalan, thalidomide and prednisone in refractory and relapsed multiple myeloma.
    Palumbo A; Avonto I; Bruno B; Ambrosini MT; Bringhen S; Cavallo F; Falco P; Boccadoro M
    Eur J Haematol; 2006 Apr; 76(4):273-7. PubMed ID: 16519697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolated thrombocytopenia induced by thalidomide in a patient with multiple myeloma: case report and review of literature.
    Prasad HK; Kaushal V; Mehta P
    Am J Hematol; 2007 Sep; 82(9):855-7. PubMed ID: 17570510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thalidomide in combination with dexamethasone-induced rhabdomyolysis in a patient with refractory myeloma.
    Boga C; Ozdogu H; Yeral M; Kizilkilic E; Tamer L
    J Support Oncol; 2007 Jun; 5(6):256. PubMed ID: 17624049
    [No Abstract]   [Full Text] [Related]  

  • 38. [Drug-induced pneumonitis associated PABRON-GOLD].
    Nomura M; Fujimura M; Matsuda T; Kitagawa M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jan; 35(1):72-6. PubMed ID: 9071160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose thalidomide plus monthly high-dose oral dexamethasone (Thali-Dexa): results, prognostic factors and side effects in eight patients previously treated with multiple myeloma.
    Bemardeschi P; Dentico P; Rossi S; Fiorentini G; Giustarini G; Turano E
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):129-33. PubMed ID: 16767919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose thalidomide regimens in therapy of relapsed or refractory multiple myeloma.
    Zemanova M; Scudla V; Adam Z; Gregora E; Pour L; Minarik J; Pavlicek P; Pika T; Bacovsky J
    Neoplasma; 2008; 55(4):345-9. PubMed ID: 18505347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.